Data Provided by Refinitiv. Minimum 15 minutes delayed.
Press Release VELIZY-VILLACOUBLAY, France — July 25, 2024 Availability of Dassault Systèmes’ 2024 Half-Year Financial Report (IFRS Half-Year Consolidated Condensed Financial Statements) Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the availability to the public and the
Press Release VELIZY-VILLACOUBLAY, France — July 25, 2024 Dassault Systèmes: Second Quarter 2024 Results in Line With Preliminary Announcement Non-IFRS Diluted EPS up 10% in the First Half Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), on the back of the July 9, 2024 preliminary
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80% New York – July 25, 2024 – Medidata , a Dassault Systèmes brand and leading provider of
Press Release VELIZY-VILLACOUBLAY, France — July 9 th , 2024 Dassault Systèmes Provides Preliminary Second Quarter 2024 Results and Full Year Outlook Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announces today preliminary non-IFRS unaudited financial results for the
Press Release VELIZY-VILLACOUBLAY, France — July 8, 2024 Declaration of the number of outstanding shares and voting rights as of June 30, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of June 30,
Béatrix Martinez, VP Investor Relations
Valerio Mazza
Delphine Da Maia-Levy / Dymphna Hawksley
Phone: +33 1 61 62 69 24/7021
Fax: +33 1 70 73 43 59
Email: investors@3ds.com